ANUHPHR

Anuh Pharma Limited

Active pharmaceutical ingredients including Erythromycin salts and Pyrazinamide

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

anuhpharma.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-19

Stock price
₹82.79
Market cap
830 Cr
Stock P/E
18.8
P/B
2.35
Dividend yield
1.8%
ROE (FY26)
11.7%
ROCE (FY26)
15.5%
Operating margin (FY26)
6.5%
Debt / equity (FY26)
0.00
OCF / EBITDA (FY26)
-4.9%
OCF / EBITDA (3Y)
23.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Anuh Pharma makes active pharmaceutical ingredients (APIs), the bulk drugs that go into finished medicines, at its Tarapur plant in Maharashtra and sells them in India and export markets.

Company snapshot

93rdBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Only 24% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales150 Cr172 Cr164 Cr138 Cr166 Cr160 Cr198 Cr186 Cr186 Cr197 Cr202 Cr194 Cr
Operating expenses (approx.)132 Cr148 Cr145 Cr127 Cr149 Cr145 Cr179 Cr176 Cr174 Cr180 Cr182 Cr178 Cr
EBITDA18 Cr24 Cr19 Cr11 Cr17 Cr15 Cr19 Cr10 Cr12 Cr17 Cr20 Cr16 Cr
OPM %12.0%13.9%11.7%7.7%10.2%9.3%9.4%5.5%6.4%8.5%9.8%8.4%
Other income2 Cr4 Cr3 Cr4 Cr3 Cr0.94 Cr1 Cr3 Cr0.98 Cr4 Cr-1 Cr3 Cr
Interest0.09 Cr0.14 Cr0.10 Cr0.14 Cr0.16 Cr0.28 Cr0.03 Cr0.21 Cr0.08 Cr0.08 Cr0.11 Cr0.0035 Cr
Depreciation2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 Cr3 Cr2 Cr
Profit before tax18 Cr25 Cr20 Cr12 Cr18 Cr13 Cr17 Cr11 Cr10 Cr18 Cr16 Cr17 Cr
Tax %22.6%24.5%22.1%22.5%17.3%22.0%27.9%24.2%23.3%24.6%24.7%32.5%
Net profit14 Cr19 Cr15 Cr10 Cr15 Cr10 Cr12 Cr8 Cr8 Cr13 Cr12 Cr11 Cr
EPS (₹)₹2.76₹3.81₹3.06₹1.90₹3.00₹2.06₹2.49₹1.66₹0.76₹1.34₹1.17₹1.14

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales217 Cr241 Cr321 Cr307 Cr432 Cr487 Cr527 Cr647 Cr662 Cr772 CrSign in free for the trailing twelve months
Operating expenses (approx.)195 Cr223 Cr291 Cr284 Cr387 Cr440 Cr476 Cr572 Cr601 Cr710 CrSign in free for the trailing twelve months
EBITDA22 Cr18 Cr30 Cr23 Cr45 Cr47 Cr51 Cr75 Cr61 Cr62 CrSign in free for the trailing twelve months
OPM %10.1%7.4%9.2%7.4%10.3%9.6%9.7%11.6%9.2%8.0%Sign in free for the trailing twelve months
Other income8 Cr7 Cr5 Cr4 Cr11 Cr5 Cr6 Cr12 Cr9 Cr4 CrSign in free for the trailing twelve months
Interest0.04 Cr0.04 Cr0.17 Cr0.79 Cr1 Cr0.96 Cr0.22 Cr0.35 Cr0.62 Cr0.47 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr2 Cr7 Cr15 Cr12 Cr10 Cr9 Cr9 Cr11 CrSign in free for the trailing twelve months
Profit before tax28 Cr23 Cr32 Cr19 Cr39 Cr39 Cr47 Cr78 Cr61 Cr54 CrSign in free for the trailing twelve months
Tax %27.3%29.5%27.9%25.3%26.2%21.9%23.8%23.3%22.4%24.3%Sign in free for the trailing twelve months
Net profit20 Cr17 Cr23 Cr14 Cr28 Cr31 Cr36 Cr60 Cr47 Cr41 CrSign in free for the trailing twelve months
EPS (₹)₹8.00₹6.59₹9.33₹5.71₹5.67₹6.10₹7.22₹11.98₹9.45₹4.10Sign in free for the trailing twelve months
Dividend payout %————-0.1%24.7%24.2%16.7%26.4%36.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital13 Cr13 Cr13 Cr13 Cr25 Cr25 Cr25 Cr25 Cr25 Cr50 Cr
Reserves128 Cr137 Cr152 Cr150 Cr166 Cr189 Cr216 Cr266 Cr301 Cr302 Cr
Borrowings—2 Cr4 Cr45 Cr14 Cr3 Cr—2 Cr10 Cr—
Other liabilities48 Cr57 Cr71 Cr120 Cr128 Cr130 Cr164 Cr152 Cr170 Cr205 Cr
Total liabilities189 Cr209 Cr240 Cr326 Cr333 Cr347 Cr405 Cr446 Cr507 Cr557 Cr
Fixed assets (net)17 Cr16 Cr21 Cr83 Cr71 Cr60 Cr52 Cr48 Cr50 Cr48 Cr
CWIP0.26 Cr6 Cr34 Cr0 Cr0 Cr0.10 Cr0 Cr0.45 Cr0.27 Cr0 Cr
Investments70 Cr66 Cr39 Cr80 Cr31 Cr43 Cr91 Cr97 Cr106 Cr84 Cr
Loans & advances——0.34 Cr1 Cr0.93 Cr0.79 Cr0.47 Cr0.62 Cr0.55 Cr0.83 Cr
Inventories30 Cr32 Cr43 Cr61 Cr81 Cr80 Cr73 Cr75 Cr74 Cr148 Cr
Trade receivables57 Cr71 Cr75 Cr81 Cr107 Cr136 Cr171 Cr190 Cr216 Cr239 Cr
Cash & bank5 Cr4 Cr7 Cr2 Cr2 Cr4 Cr2 Cr7 Cr20 Cr8 Cr
Other assets9 Cr14 Cr22 Cr18 Cr39 Cr24 Cr16 Cr27 Cr41 Cr30 Cr
Total assets189 Cr209 Cr240 Cr326 Cr333 Cr347 Cr405 Cr446 Cr507 Cr557 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity26 Cr2 Cr7 Cr49 Cr-19 Cr29 Cr54 Cr13 Cr37 Cr-3 Cr
Cash from investing-20 Cr2 Cr3 Cr-77 Cr52 Cr-8 Cr-43 Cr0.92 Cr-20 Cr18 Cr
Cash from financing-4 Cr-5 Cr-7 Cr22 Cr-33 Cr-19 Cr-12 Cr-9 Cr-5 Cr-26 Cr
Net cash flow2 Cr-1 Cr3 Cr-5 Cr0.35 Cr2 Cr-2 Cr5 Cr12 Cr-11 Cr
Free cash flow (OCF − Capex)25 Cr-5 Cr-22 Cr13 Cr-25 Cr27 Cr52 Cr8 Cr17 Cr-11 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %19.7%15.4%19.3%9.6%19.6%18.5%19.8%26.8%18.3%15.5%
ROE %14.3%11.0%14.2%8.8%14.9%14.3%15.0%20.6%14.5%11.7%
Debtor days95107859690102118107119113
Inventory days756364949183705659105
Days payable10610387159135126147105123134
Cash conversion cycle64676131475841595484
OCF / EBITDA %118.7%10.2%24.1%214.9%-42.0%61.6%105.1%17.2%61.0%-4.9%
OCF / EBITDA % (3 years)——50.5%82.5%38.5%51.7%44.9%55.2%55.5%23.8%
Debt / equity—0.020.030.270.070.010.000.00690.030.00
Current ratio2.912.632.031.381.701.981.912.202.112.22
Net debt / EBITDA-0.24-0.08-0.101.880.26-0.01-0.04-0.07-0.15-0.13